Related Experiment Videos
Inhibitor development in a multitransfused patient with severe haemophilia A
Thrombosis and Haemostasis
|August 24, 1999
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Antibodies against recombinant alpha-galactosidase A in Fabry disease: Subclass analysis and impact on response to treatment.
Molecular genetics and metabolism·2018
Clinically relevant differences between assays for von Willebrand factor activity.
Journal of thrombosis and haemostasis : JTH·2018
Anticoagulation therapy in haemophilia.
Hamostaseologie·2018
Divergent Effects of Estradiol Regimens on Protein S and Global Coagulation in Transgender Women.
Thrombosis and haemostasis·2026
Ambient Particulate Matter Exposure and Risk of Venous Thromboembolism: An Updated Systematic Review and Meta-Analysis.
Thrombosis and haemostasis·2026
Mouse models to study von Willebrand Factor in hemostasis: a scoping review.
Thrombosis and haemostasis·2026
Clinical Validation of a Point-of-Care Whole Blood Coagulometer in Patients on Factor Xa Inhibitors.
Thrombosis and haemostasis·2026
Prognostic Role of Blood Inflammatory Composite Biomarkers in Dvt After Lower Extremity Fractures.
The Iowa orthopaedic journal·2026
Pattern of blood utilization and blood wastage at blood bank of a tertiary care hospital in Lahore.
Pakistan journal of medical sciences·2026
Coagulation potential of concomitant factor VIII administration in people with hemophilia A receiving emicizumab prophylaxis (CAGUYAMA study): a multicenter, open-label, nonrandomized clinical trial.
Research and practice in thrombosis and haemostasis·2026
Management and outcomes in patients with cryptogenic stroke and weakly positive antiphospholipid antibodies.
Research and practice in thrombosis and haemostasis·2026